Dynamics of Lipid Profile in Antiretroviral-Naïve HIV-Infected Patients, Treated with TAF-Based Regimens: A Multicenter Observational Study

Background: The introduction of tenofovir alafenamide (TAF) in antiretroviral therapy has deeply modified the choice of the backbone for different treatment regimens, allowing the prevention of the bone and renal toxicity that was related to the previous formulation of tenofovir disoproxil fumarate...

Descripción completa

Detalles Bibliográficos
Autores principales: Martini, Salvatore, Maggi, Paolo, Gervasoni, Cristina, Onorato, Lorenzo, Ferrara, Sergio, Alessio, Loredana, Bellacosa, Chiara, Esposito, Vincenzo, Di Filippo, Giovanni, Masiello, Addolorata, Maddaloni, Adelaide, Madonia, Simona, D’Alessio, Giovanna, Rizzo, Viviana, Coppola, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775227/
https://www.ncbi.nlm.nih.gov/pubmed/36551920
http://dx.doi.org/10.3390/biomedicines10123164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775227/
https://www.ncbi.nlm.nih.gov/pubmed/36551920
http://dx.doi.org/10.3390/biomedicines10123164

Ejemplares similares